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sing a microinjection approach to study apical
plasma membrane protein trafﬁcking in hepatic
cells, we found that speciﬁc inhibition of Vps34p, a
class III phosphoinositide 3 (PI-3) kinase, nearly perfectly
recapitulated the defects we reported for wortmannin-
 
treated cells (Tuma, P.L., C.M. Finnegan, J.-H Yi, and
 
A.L. Hubbard. 1999. 
 
J. Cell Biol.
 
 145:1089–1102). Both
wortmannin and injection of inhibitory Vps34p antibodies
led to the accumulation of resident apical proteins in en-
larged prelysosomes, whereas transcytosing apical proteins
and recycling basolateral receptors transiently accumulated
in basolateral early endosomes. To understand how the
Vps34p catalytic product, PI(3)P, was differentially regulat-
ing endocytosis from the two domains, we examined the
U
 
PI(3)P binding protein early endosomal antigen 1 (EEA1).
We determined that EEA1 distributed to two biochemically
distinct endosomal populations: basolateral early endosomes
and subapical endosomes. Both contained rab5, although
the latter also contained late endosomal markers but was
distinct from the transcytotic intermediate, the subapical
compartment. When PI(3)P was depleted, EEA1 dissociated
from basolateral endosomes, whereas it remained on sub-
apical endosomes. From these results, we conclude that
PI(3)P, via EEA1, regulates early steps in endocytosis from
the basolateral surface in polarized WIF-B cells. However,
PI(3)P must use different machinery in its regulation of the
apical endocytic pathway, since later steps are affected by
Vps34p inhibition.
 
Introduction
 
Epithelial cells line all organs of the body and provide a
selective barrier between the external and internal worlds.
Intercellular junctions establish this barrier by cementing
the cells together, thus restricting distinct cellular activities
to either the apical or basolateral plasma membrane (PM)*
domain. Such functional asymmetry (or polarity) reflects
the differential distribution of PM proteins in the two
domains. Studies identifying the molecular sorting mecha-
nisms and pathways by which newly synthesized PM pro-
teins achieve their specific, yet asymmetric, distributions
indicate that there is great plasticity among cell types and
membrane protein classes (Keller and Simons, 1997; Tuma
and Hubbard, 2001).
 
Although much less is known about how proteins are
retained at their specific domains or what regulates their
turnover, there seems to be plasticity in these processes also.
In particular, differences in the mechanisms regulating inter-
nalization from the two domains have been described (Gott-
lieb et al., 1993; Jackman et al., 1994; Holm et al., 1995;
Llorente et al., 1996; Shurety et al., 1996). We have been
examining one such difference in polarized hepatocytes. Us-
ing the phosphoinositide 3 (PI-3) kinase inhibitors, wort-
mannin and LY294002, we found that endocytic trafficking
of resident membrane proteins from the hepatic apical do-
main was under the control of PI-3 kinase activity, whereas
internalization of basolateral residents was not (Tuma et al.,
1999).
Of the three classes of mammalian PI-3 kinases, only
classes I and III are inhibited by the relatively low wortman-
nin concentrations used in our published studies. Class I in-
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cludes the p85/p110 heterodimeric kinases which consist of
a 110-kD catalytic subunit associated with a regulatory 85-
kD subunit. The other member is PI3K-
 
 
 
, whose catalytic
activity is regulated by the 
 
  
 
 subunits of heterotrimeric
G-proteins (Fruman et al., 1998; Backer, 2000). Class III is
the homologue of the sole PI-3 kinase expressed in yeast
 
,
 
Vps34p (Herman and Emr, 1990; Volinia et al., 1995).
This kinase is also under the control of a regulatory subunit,
p150 (in mammalian cells) or Vps15p (in yeast) (Herman et
al., 1991; Panaretou et al., 1997).
Both the p85/p110 and Vps34p/p150 PI-3 kinases have
been implicated in regulating endocytic membrane trans-
port (Shepherd et al., 1996; Backer, 2000), preventing the
direct identification of the enzyme inhibited in our wort-
mannin studies. To discriminate which kinase was in-
volved, we took a direct approach and injected specific in-
hibitory reagents. For the class I kinases, we injected
inhibitory antibodies raised against the p110
 
 
 
 or 
 
 
 
 catalytic
subunits or we injected glutathione 
 
S
 
-transferase (GST) fu-
sion proteins encoding the NH
 
2
 
-terminal SH2 (nSH2) do-
main of the p85 regulatory subunit that has been used ex-
tensively as an inhibitor of activated p110 catalytic subunits
(Jhun et al., 1994; Hill et al., 2000). For the class III lipid
kinase activity, we injected inhibitory Vps34p antibodies
(Siddhanta et al., 1998). In vitro, these antibodies signifi-
cantly and selectively decreased the catalytic activity of their
respective kinases; when injected into either CHO or
HepG2 cells, the antibodies inhibited different membrane
transport steps (Siddhanta et al., 1998). Using these inhibi-
tory reagents in polarized hepatic cells, we found that spe-
cific inhibition of the class III PI-3 kinase, Vps34p, led to
the formation of prelysosomal vacuoles containing endocy-
tosed resident apical PM proteins and to the transient accu-
mulation of transcytosing apical membrane proteins in ba-
solateral early endosomes. These results indicate that the
lipid product of Vps34p, PI(3)P, regulates the two en-
docytic pathways differentially at an early endosomal stage
from the basolateral surface, and from prelysosomes to lyso-
somes from the apical surface.
 
Results
 
Injection of Vps34p antibodies induces formation of 
vacuoles that contain apical PM and lysosomal 
membrane proteins
 
To determine which PI-3 kinase(s) was responsible for the
wortmannin-induced changes we have described previously
(Tuma et al., 1999), we examined the distributions of resi-
dent apical proteins and lysosomal membrane proteins in
cells injected with specific inhibitory reagents. As shown in
Fig. 1 a, cells injected with anti-Vps34p were heavily vacu-
olated 4 h after injection and these vacuoles, which were
also readily apparent in cells stained for the injected anti-
bodies (Fig. 1, b and c), strongly resembled those induced
by wortmannin (Tuma et al., 1999). In the injected cells,
low but detectable amounts of apical PM proteins were ob-
Figure 1. Injection of anti-Vps34p induces formation of vacuoles 
that contain apical PM proteins. WIF-B cells were injected with 
anti-Vps34p (a–d) or anti-RSA (e and f). 4 h postinjection, cells were 
labeled for the injected antibodies (b, c, f, and g) or 5 NT (d and h). 
Phase micrographs are shown in panels a and e. Arrowheads point 
to vacuoles containing 5 NT (d and h). Asterisks mark bile cana-
liculi (BCs) of injected cells. The data are representative of four 
experiments. Bar, 10  m.
Figure 2. Lysosomal membrane proteins accumulate in anti-
Vps34p–induced vacuoles. WIF-B cells were injected with anti-
Vps34p (a and b) or anti-RSA (c and d). 4 h postinjection, cells were 
double-labeled for the injected antibodies (a and c) and endolyn-78 
(b and d). Arrowheads point to vacuoles containing endolyn-78. 
Asterisks mark BCs of injected cells. The data are representative of 
three experiments. Bar, 10  m. 
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served in vacuoles (5
 
 
 
NT, Fig. 1 d; and dipeptidyl pepti-
dase IV (DPP IV), unpublished data). No changes in resi-
dent basolateral PM protein distributions were observed
(unpublished data). To control for the injection process it-
self, cells were injected with anti–rat serum albumin
(RSA). By phase (Fig. 1 e) and immunofluorescence mi-
croscopy (Fig. 1, f and g), no vacuoles formed and 5
 
 
 
NT
distribution was normal (Fig. 1 h). Lysosomal membrane
proteins also redistributed to the vacuoles induced by anti-
Vps34p injection (endolyn-78, Fig. 2 b; lysosomal glyco-
protein of 120 kD (LGP-120), unpublished data), but
were not changed after anti-RSA injection (Fig. 2 d).
We saw no vacuole formation in cells injected with anti-
p110
 
 
 
 (Fig. 3 a) or anti-p110
 
 
 
 (Fig. 3, c and d). Further-
more, neither 5
 
 
 
NT (Fig. 3 b) nor endolyn-78 distributions
(unpublished data) were altered in the injected cells. To con-
firm that class I kinases were not regulating apical mem-
brane dynamics, we injected another specific inhibitor, the
nSH2 domain of the p85 regulatory subunit. Importantly,
this domain inhibits kinase activity by a different mecha-
nism than the antibodies and has been used extensively as an
inhibitor of activated p85/p110 heterodimers (Jhun et al.,
1994). Injection of the nSH2 domain had no observable ef-
fects on the morphology of injected cells (Fig. 3 e) or the
distributions of 5
 
 
 
NT (Fig. 3 f) or endolyn-78 (unpublished
data). Together, these results indicate that Vps34 specifically
regulates the dynamics of resident apical PM proteins.
 
The apical PM proteins in vacuoles come from the 
apical PM
 
In our previous study with wortmannin, we found that the
apical PM proteins in vacuoles came from the apical surface
itself (Tuma et al., 1999). To determine whether this was
also the case in anti-Vps34p–injected cells, we monitored
Figure 3. WIF-B morphology and apical PM protein distributions 
do not change in cells injected with anti-p110 , anti-p110 , or 
nSH2 domains. WIF-B cells were injected with anti-p110  (a and b) 
or anti-p110  (c and d) or nSH2 domains (e and f). 4 h postinjec-
tion, cells were labeled for the injected antibodies (a and c), the 
fusion protein (e), or 5 NT (b and f). The phase micrograph for the 
anti-p110 –injected cells is shown (d). Asterisks mark BCs of 
injected cells. The data are representative of at least three experi-
ments. Bar, 10  m.
Figure 4. Anti-Vps34p and anti-p110  impair basolateral to apical 
transcytosis of apical proteins, but transcytosing molecules do not 
accumulate in vacuoles. (A) Cells were injected with anti-Vps34p (a 
and b), -p110  (c and d), or -p110  (e and f) and recovered for 2 h. 
5 NT molecules present at the basolateral PM were labeled with anti-
bodies for 15 min at 4 C and the antibody–antigen complexes were 
chased for 3 h at 37 C. The cells were then fixed and permeabilized 
and the trafficked molecules visualized with secondary antibodies. 
Injected antibody staining is shown in a, c, and e while staining of the 
trafficked 5 NT is shown in b, d, and f. Asterisks indicate the BCs of 
injected cells. Arrowheads in panel b point to the intracellular accu-
mulations of trafficked 5 NT in anti-Vps34p–injected cells, and the 
arrows in panels c and d point to unlabeled apical PM in anti-p110 –
injected cells. (B) Cells were injected and labeled for 5 NT as 
described in the legend to A, except the antibody–antigen complexes 
were chased for 0, 90, or 180 min. For each time point, injected cells 
were scored for the relative intensity of anti-5 NT immunofluores-
cence (BC Staining) present at the apical PM. Black bars represent the 
percentages obtained from control, uninjected neighboring cells 
(con), while the open bars represent injected cells (inj). Only polar-
ized cells were included in the analysis. Approximately 85–180 cells 
were examined for each time point. Values are expressed as the
mean   SD. Measurements were performed on at least three experi-
ments. Bar, 10  m. 
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the fates of staged apical proteins labeled with specific anti-
bodies. First, we sought to exclude the transcytotic pathway
as the source. For these experiments, cells were injected with
the inhibitory antibodies or nSH2 and allowed to recover
for 2 h at 37
 
 
 
C (during which time vacuoles formed in anti-
Vps34p–injected cells). The basolateral pool of 5
 
 
 
NT (those
molecules en route to the apical domain) was labeled with
antibodies at 4
 
 
 
C in live cells, the cells were warmed to 37
 
 
 
C
and the antibody–antigen complexes chased for 3 h. The
cells were fixed and permeabilized and the trafficked com-
plexes was visualized with secondary antibodies.
Cells injected with anti-Vps34p showed altered basolat-
eral-to-apical transcytosis, but this pathway did not contrib-
ute to the vacuolar pool of apical proteins. Trafficked 5
 
 
 
NT
was found near the apical PM in multiple puncta that were
not present in neighboring, uninjected cells (Fig. 4 b). Al-
though 
 
 
 
50% (51.7 
 
 
 
 13.4%) of the injected cells con-
tained the trafficked intermediates, it is important to em-
phasize that these structures were distinct from the large
vacuoles containing apical proteins at steady state (Fig. 1 d).
Furthermore, like wortmannin, anti-Vps34p was slowing
but not inhibiting transcytosis (Cardone and Mostov, 1995;
Hansen et al., 1995; Tuma et al., 1999). In uninjected
neighbors, the apical PM stained brightly for 5
 
 
 
NT, but this
staining was absent in injected cells (Fig. 4 b). The lag in de-
livery was more apparent when apical labeling was quanti-
fied (Fig. 4 B). By 90 min, 
 
 
 
95% of control apical surfaces
were positive for 5
 
 
 
NT staining, whereas in injected cells,
 
 
 
45% were labeled. After 180 min, more apical domains
were labeled (
 
 
 
65%) in the injected cells indicating in-
creased delivery of 5
 
 
 
NT.
In cells injected with anti-p110
 
 
 
, p110
 
 
 
 (Fig. 4, d and f,
respectively) or nSH2 domains (unpublished data), transcy-
tosing proteins behaved differently. Surprisingly, injection
of anti-p110
 
 
 
 impaired 5
 
 
 
NT transcytosis to a similar ex-
tent to that seen with anti-Vps34p (Fig. 4 B). Little to no
5
 
 
 
NT staining was observed at the apical surface, with a cor-
responding increase in staining at the basolateral surface.
Furthermore, no intracellular intermediates were observed;
 
 
 
5% (4.5 
 
 
 
 5.2%) of the anti-p110
 
 
 
–injected cells con-
tained intracellular populations of trafficked 5
 
 
 
NT (Fig. 4
d). In anti-p110
 
 
 
–injected cells, apical labeling by trafficked
5
 
 
 
NT was morphologically (Fig. 4 f) and quantifiably (un-
published data) indistinguishable from the uninjected neigh-
bors. Similarly, no impairment in transcytosis was observed
in cells injected with nSH2 (unpublished data).
To directly determine that the apical PM was the source
of the apical proteins found in anti-Vps34p–induced vacu-
oles, we monitored the fate of 5
 
 
 
NT molecules staged at the
apical surface. The basolateral pool of 5
 
 
 
NT was labeled as
described above but was followed by a prolonged 5 h chase
at 37
 
 
 
C to allow complete apical delivery of the antibody–
antigen complexes. The cells were then injected with anti-
Vps34p and incubated an additional 4 h before fixation,
permeabilization, and labeling with secondary antibodies to
detect the trafficked complexes. As shown in Fig. 5, a and b,
virtually all of the trafficked 5
 
 
 
NT was detected at the apical
PM in control cells. Since transcytosing molecules did not
accumulate in anti-Vps34p–induced vacuoles (Fig. 4), the
small amount of 5
 
 
 
NT remaining at the basolateral surface
did not contribute to vacuolar staining. In cells injected with
anti-Vps34p, vacuoles were observed (Fig. 5, c and e, ar-
rows) that contained 5
 
 
 
NT (Fig. 5, d and f). Similar results
were seen for trafficked aminopeptidase N
 
 
 
(APN) (unpub-
lished data). Thus, the apical PM proteins found in vacuoles
came from the apical PM. The relatively low level of 5
 
 
 
NT
vacuolar accumulation likely reflects its low degradative rate
(
 
t
 
1/2
 
 
 
 
 
 
 
 
 
2 d; unpublished data) and slow transport to lyso-
somes.
To further confirm these results, we examined the distri-
butions of the polytopic apical PM protein, multidrug resis-
tance–associated protein 2
 
 
 
(MRP2), in wortmannin-treated
WIF-B cells. Importantly, this apical protein is localized ex-
clusively to the apical PM in untreated WIF-B cells (Fig. 5
g). After treatment for 3 h, MRP2 staining was observed on
large wortmannin-induced vacuoles (Fig. 5 h), indicating
that the source of apical proteins in vacuoles was the apical
PM. These data show that specific inhibition of Vps34p
nearly perfectly recapitulated the defects we reported for
Figure 5. The apical proteins in vacuoles come from the apical 
PM. (a–f) 5 NT antibody–antigen complexes were chased to the 
apical PM for 5 h at 37 C. The cells shown in panels c–f were 
injected with anti-Vps34p and incubated an additional 4 h. In a and 
b, 5 NT staining in uninjected cells is shown. Cells double-labeled 
for the injected antibody and trafficked 5 NT are shown in c and e 
and d and f, respectively. Arrows are pointing to anti-Vps34p–
induced vacuoles that contain apical PM proteins after the addi-
tional chase. The data are representative of four experiments. (g and 
h) WIF-B cells were incubated for 3 h in the absence (g) or presence 
of 100 nM wortmannin (wtm; h) and stained for MRP2. In untreated 
cells, MRP2 is detected only at the apical PM (g). Arrowheads point 
to MRP2-positive vacuoles in treated cells (h). Bars, 10  m. 
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wortmannin-treated cells and indicate that Vps34p regulates
two stages of apical membrane dynamics: apical endocytic
trafficking and basolateral to apical transcytosis.
 
Vps34p differentially regulates endocytosis from the 
apical and basolateral surfaces
 
To better define the steps in endocytosis that PI(3)P lipids
were regulating in polarized WIF-B cells, we established the
intermediates that wortmannin (and anti-Vps34p) treatment
 
induced. In our earlier study, we reported that wortmannin
treatment for 180 min mainly led to formation of vacuoles
containing lysosomal and apical PM proteins. However, we
observed transient early or late endosomal vacuole popula-
tions after shorter incubations. Neither population over-
lapped extensively with the vacuoles marked by endolyn-78.
After 90 min of wortmannin treatment, asialoglycoprotein
receptor
 
 
 
(ASGP-R) (Fig. 6, a and b) and mannose 6-phos-
phate receptor (M6P-R) (Fig. 6, c and d) distributed to vacu-
oles distinct from those containing endolyn-78.
Since previous studies have shown that vacuoles containing
lysosomal membrane proteins were not mature lysosomes,
but enlarged prelysosomes (Reaves et al., 1996), we examined
lysosome morphology in wortmannin-treated WIF-B cells.
We first visualized all acidic compartments using lysotracker
and identified two compartments: large vacuoles whose rims
were stained and smaller, homogeneously stained structures
(Fig. 6, e and f). To determine whether the smaller structures
Figure 6. Wortmannin induces formation of distinct vacuole pop-
ulations, but does not alter mature lysosome morphology. In pan-
els a–d, cells were treated for 90 min with 100 nM wortmannin. The 
relative distributions of endolyn-78 to ASGP-R (a and b) or M6P-R (c 
and d) are shown. Arrows in a and b are pointing to structures that 
only contain ASGP-R, and in c and d that contain only M6P-R. In 
e–k, cells were treated for 180 min with 100 nM wortmannin. In e 
and f, 50 nM lysotracker was added in the final 30 min of wortman-
nin treatment. Lysotracker staining of acidic compartments in live 
cells is shown in panel f, and the corresponding phase image in 
panel e. Enlarged images of wortmannin-treated cells double-
labeled for endolyn-78 (h) and cathepsin D (cath D, g) are shown. 
Arrowheads indicate small puncta containing endolyn at the surface 
and cathepsin D in the lumen. In panels i–k, 50  M leupeptin was 
included hourly in the wortmannin incubations to inhibit acid 
hydrolase activity. Arrows are pointing to small puncta that contain 
5 NT in panel i. Arrows in the enlarged, double-labeled images in j 
and k are pointing to the small 5 NT-positive puncta that also con-
tain cathepsin D. The data are representative of at least three exper-
iments. Bars, (a–f and i) 10  m; (g and h) 2  m; and (j and k) 5  m.
Figure 7. Transcytosing apical proteins and recycling receptors 
internalized from the basolateral PM accumulate in basolateral 
early endosomes in wortmannin-treated cells. WIF-B cells were 
treated in the absence (a, b, e, and f) or presence (c, d, and g–j) of 
100 nM wortmannin for 2 h. 5 NT and ASGP-R (a–c) or 5 NT and 
M6P-R (e–h) at the basolateral PM were colabeled for 1 h at 37 C in 
the continued absence or presence of wortmannin. Arrows are 
pointing to structures containing both trafficked 5 NT and ASGP-R 
(c and d) or both 5 NT and M6P-R (g and h). In i and j, 5 NT present 
at the basolateral PM was continuously labeled for 1 h at 37 C in 
the presence of wortmannin and its distributions were examined
relative to M6P-R at steady state. The data are representative of at 
least three experiments. Bar, 10  m.1202 The Journal of Cell Biology | Volume 154, Number 6, 2001
were mature lysosomes (also called dense core lysosomes;
Reaves et al., 1996), we labeled treated cells for acid hydro-
lases. As shown in Fig. 6 g, cathepsin D distributed to small
puncta that were distinct from the large, endolyn-78–positive
vacuoles (Fig. 6 h). In these enlarged images, we also saw that
endolyn-78 was present in the smaller, cathepsin D–positive
structures. In some cases, the limiting membrane was positive
for endolyn-78, whereas cathepsin D labeled only the lumen
(arrows in Fig. 6, g and h). Furthermore, when 5 NT distri-
bution was examined in treated cells in the presence of leu-
peptin (to inhibit lysosomal hydrolase activity), additional
staining was observed in small puncta (Fig. 6 i). Double la-
beling with cathepsin D revealed that these structures were
lysosomes, indicating that resident apical proteins were deliv-
ered to functional lysosomes (Fig. 6, j and k). Together, these
results imply the presence of at least four endocytic interme-
diates in WIF-B cells: early endosomes (ASGP-R ), late
endosomes (M6P-R ), prelysosomes/multivesicular bodies
(MVBs) (endolyn-78 ), and mature lysosomes (endolyn-
78 , cathepsin D ; see Fig. 10). Since the apical PM pro-
teins were detected at later time points in vacuoles that con-
tained only endolyn-78, we conclude that they accumulated
in prelysosomes before delivery to lysosomes.
In contrast to the resident apical proteins, the transcytosing
apical proteins accumulated transiently in other intracellular
structures. To date, only two transcytotic intermediates have
been defined in polarized hepatic cells: basolateral early endo-
somes and the subapical compartment (SAC) (see Fig. 10;
Barr et al., 1995; Ihrke et al., 1998). Since the SAC was un-
changed by wortmannin treatment (Tuma et al., 1999), it
was likely that the transcytosing proteins accumulated in ba-
solateral early endosomes. To test this possibility, we simulta-
neously monitored the trafficking of transcytosing apical pro-
teins and ASGP-R or M6P-R from the basolateral surface. If
the block occurred early in endocytic transport, these pro-
teins, with different final destinations, should have accumu-
lated in the same structures. Cells were pretreated for 2 h
with 100 nM wortmannin. Antibodies to the different mark-
ers were then applied continuously for an additional hour at
37 C in the presence of wortmannin and their distributions
were determined. As described previously (Ihrke et al., 1998)
and shown in Fig. 7, 5 NT (Fig. 7, a and e), ASGP-R (Fig. 7
b), and M6P-R (Fig. 7 f) were delivered to their resident
compartments in control cells (the apical PM, early and late
endosomes, respectively). In treated cells, trafficked 5 NT
and ASGP-R accumulated in the same intracellular compart-
ments (Fig. 7, c and d) as did 5 NT and M6P-R (Fig. 7, g
and h). Similar results were observed in cells injected with
anti-Vps34p (unpublished data). Importantly, the steady
state distribution of M6P-R in treated cells remained mostly
distinct from the trafficked 5 NT (Fig. 7, i and j) and by ex-
tension, the trafficked M6P-R (compare Figs. 7, h and j), in-
dicating that the dynamics of the late endosomal protein were
inhibited at an earlier step. From these results, we conclude
that wortmannin and anti-Vps34p impaired an early step in
basolateral endocytosis in WIF-B cells (see Fig. 10).
Apical and basolateral early endosomes are 
biochemically distinct
Current models of the role played by PI(3)P lipids in mam-
malian cell endocytosis focus on early endosomal antigen 1
(EEA1), a PI(3)P-binding protein whose activity appears to
Figure 8. EEA1 is localized to endo-
somes near the apical PM and the cell 
periphery that are biochemically 
distinct. WIF-B cells were double-
labeled for EEA1 and ASGP-R (a–d), 
EEA1 and M6P-R (e–h), EEA1 and rab5 
(i–l), or EEA1 and syntaxin13 (syn 13; 
m–p). In a–c, e–g, i–k, and m–o, the 
images were focused at the BC, whereas 
in d, h, i, and p, they were focused at the 
cell periphery. The merged images from 
a b, e f, i, j, m, and n are shown in c, g, 
k, and o, respectively. Only the merged 
images taken at the cell periphery are 
shown in d, h, i, and p. In panels q–t, 
EEA1 steady state distributions (r) are 
shown relative to endolyn-78 molecules 
that have been trafficked to the SAC (s). 
The merged image is shown in panel t. 
The data are representative of at least 
three experiments. Bar, 10  m.Vps34p regulates membrane transport in hepatocytes | Tuma et al. 1203
be required in early endosome fusion events (Corvera and
Czech, 1998; McBride et al., 1999; Stenmark and Aasland,
1999; Backer, 2000). Although our results pointing to a
block at an early stage in basolateral endocytosis are consis-
tent with such models, those results indicating a block in
late endocytic transport are not. Furthermore, there is a par-
adox between the results of wortmannin treatment in vitro,
where EEA1 activity and membrane fusion are inhibited,
and in cells, where large membrane vacuoles form. This lat-
ter phenomenon implies that membrane fusion is not inhib-
ited in vivo.
To begin sorting out this paradox, we examined EEA1
distributions in WIF-B cells (see Fig. 10). In control cells,
EEA1 was found on two membrane populations: on large
puncta near the apical PM (Fig. 8, a, e, i, m, and r) and on
smaller structures in the cell periphery (Fig. 8, d, h, l, and p).
As shown in Fig. 8, a–c, the large, apical EEA1–positive
puncta minimally colocalized with ASGP-R, another early
endosome marker, whereas substantial overlap of the stain-
ing patterns was observed in the cell periphery (Fig. 8 d).
Surprisingly, the staining patterns for EEA1 and M6P-R (a
late endosome marker) almost completely overlapped near
the apical surface (Fig. 8, e–g). In contrast, very little M6P-R
was detected in the cell periphery and no colocalization with
EEA1 was observed (Fig. 8 h). We also determined the rela-
tive distributions of other regulators of endocytosis, rab5
and syntaxin13, and observed rab5 staining on both EEA1-
positive populations (Fig. 8, i–l). However, syntaxin13 was
found with EEA1 only in the cell periphery (Fig. 8, m–p).
Due to the close proximity of the EEA1-positive struc-
tures to the apical surface, we sought a way to determine
whether they were distinct from the transcytotic intermedi-
ate, the SAC. Since basolaterally internalized endolyn-78 is
delivered to SAC before its transport to lysosomes (Ihrke et
al., 1998), we determined the distribution of trafficked en-
dolyn-78 relative to that of EEA1. The basolateral pool of
endolyn-78 was continuously labeled with antibodies for 1 h
at 37 C and then visualized with secondary antibodies. As
shown in Fig. 8 s, a substantial proportion of the endoyn-78
population was present near the apical surface in structures
corresponding to the SAC (Ihrke et al., 1998). However,
these structures were clearly distinct from those labeled with
EEA1 (Fig. 8 t). Thus, the SAC and the EEA1 apical endo-
somes are distinct compartments.
To further understand how PI(3)P depletion was perturb-
ing endocytosis, we examined EEA1 distributions in WIF-B
cells treated with wortmannin or anti-Vps34p antibodies.
To do so biochemically, we prepared cytoplasmic and total
membrane fractions from control cells or cells treated with
100 nM wortmannin and blotted them with antibodies rec-
ognizing the COOH- (Fig. 9 A) or NH2-terminal domain
(unpublished data) of EEA1. Greater than 75% of EEA1
was found in the soluble fraction using either antibody
(lanes 1 and 2). As reported previously (Patki et al., 1997),
the majority of the membrane-associated EEA1 population
was eluted after incubations with wortmannin (lanes 3–8),
however,  8% of the pelleted population ( 2% of the to-
tal) remained associated (compare lane 2 with 4, 6, and 8).
The morphological distributions of EEA1 also changed in
treated cells. Although the overall signal decreased, a signifi-
cant fraction remained associated with small puncta and
large vacuoles located near the apical PM; little to no stain-
ing was observed in the periphery (unpublished data and see
below). In wortmannin-treated cells, EEA1 staining partially
colocalized with ASGP-R (Fig. 9 B, a–c), but significantly
overlapped with rab5 (Fig. 9 B, d–f). The conditions used to
detect rab5 were not optimal for EEA1 detection, such that
EEA1 staining in panel d was less intense than in other pan-
Figure 9. Wortmannin and injection of anti-Vps34p alter EEA1 
distributions. (A) Cytosolic (lanes 1, 3, 5, and 7) and membrane 
fractions (lanes 2, 4, 6, and 8) were prepared from WIF-B cells 
treated for 0 (lanes 1 and 2), 30 (lanes 3 and 4), 60 (lanes 5 and 6), 
or 120 min (lanes 7 and 8) with 100 nM wortmannin. Equal 
volumes of the supernatant and pelleted fraction were loaded and 
immunoblotted with anti-EEA1. (B) WIF-B cells were incubated for 
90 or 180 min with 100 nM wortmannin (a–f and g–i, respectively). 
Cells were fixed, permeabilized, and double-labeled for EEA1 and 
ASGP-R (a and b), rab5 (d and e), or M6P-R (g and h). Merged
images are shown in c, f, and i. Arrowheads point to structures con-
taining both EEA1 and the indicated marker. WIF-B cells were
injected with anti-Vps34p, and after 4 h were double-labeled for the 
injected antibodies (j) and EEA1 (k). Images were focused at slightly 
different focal planes to better visualize the injected cell in panel j, 
and EEA1 vacuolar staining in panel k. Arrowheads point to vacu-
oles containing EEA1. The asterisk marks the BC of the injected cell 
and the star marks the BC of an uninjected cell. In panels l and m, 
cells were treated with 100 nM wortmannin for 120 min. ASGP-R at 
the basolateral surface was continuously labeled with antibodies for 
an additional hour in the presence of wortmannin. Trafficked
ASGP-R distributions (m) were determined relative to EEA1 at steady 
state (l). The merged image is shown in n. The data are representa-
tive of at least three experiments, except in j and k, which are repre-
sentative of two experiments. Bar, 10  m.1204 The Journal of Cell Biology | Volume 154, Number 6, 2001
els. Nonetheless, nearly every EEA1-positive structure de-
tected also contained rab5. Although the M6P-R–positive
compartments were less discrete and more tubulated in
treated cells (Fig. 9 B, h), there was also considerable overlap
between EEA1 and M6P-R staining patterns (Fig.9 B, g–i).
EEA1 was also detected in vacuoles that contained apical
PM proteins in wortmannin-treated (unpublished data) and
anti-Vps34p–injected cells (Fig. 9 B, j and k). 4 h after injec-
tion, EEA1 staining was visible on large vacuoles, whereas in
the uninjected neighbor, only small puncta were observed
(Fig. 9 B, k).
If the mechanisms regulating endocytosis from the baso-
lateral domain are consistent with current models, EEA1 in
treated cells should be dissociated from early endosomes that
contain the accumulated trafficked molecules (see Fig. 7). As
described above, cells were pretreated for 2 h with 100 nM
wortmannin and anti–ASGP-R was continuously applied
for an additional hour at 37 C in the presence of wortman-
nin. No overlap was seen between EEA1 at steady state and
trafficked ASGP-R (Fig. 9 B, l–n). However, EEA1 re-
mained associated with the apically located, M6P-R–posi-
tive structures, suggesting it remained functional in endocy-
tosis from the apical domain so that blocks in late endocytic
transport were revealed.
Discussion
By adopting a microinjection approach, we determined that
specific inhibition of the class III PI-3 kinase, Vps34p, in
polarized WIF-B cells led to the formation of prelysosomal
vacuoles containing endocytosed resident apical PM pro-
teins, and also to the transient accumulation of transcytosing
apical membrane proteins in basolateral early endosomes.
These results indicate that the lipid product of Vps34p,
PI(3)P, regulates the two endocytic pathways differentially
at an early endosomal stage in the basolateral arm, and later
in the apical arm. In support of this conclusion, marker
analysis of the PI(3)P-binding protein, EEA1, and other
known regulators of early endocytosis revealed biochemical
differences between early apical and basolateral endosomes.
Furthermore, EEA1 was differentially retained on apical, but
not basolateral, early endosomes when PI(3)P was depleted
from WIF-B cells. From these combined results, we con-
clude that regulation by EEA1 and PI(3)P of the basolateral
endocytic pathway in polarized hepatic cells is consistent
with a current model of early endosomal events, but that
other mechanisms/players must be acting in the apical path-
way of polarized WIF-B cells.
Vps34p differentially regulates endocytosis from the 
apical and basolateral domains
The current model of PI(3)P’s role in endocytosis invokes
recruitment of Vps34p/p150 by activated rab5 to the sites of
endosome–endosome fusion and local production of PI(3)P
(Corvera and Czech, 1998; Stenmark and Aasland, 1999;
McBride et al., 1999; Backer, 2000). EEA1 is then recruited
to these sites where PI(3)P and rab5 binding stabilize its
membrane association. The stabilized EEA1 molecules then
form oligomers that coordinate the formation of a large vesi-
cle docking site also containing NSF and syntaxin13, all of
which drive endosome fusion. Thus, in nonpolarized cells,
when PI(3)P lipids were depleted by wortmannin, EEA1 as-
sociation with early endosomes was lost and the subsequent
events were affected. Likewise, we found that EEA1 dissoci-
ated from basolateral early endosomes in treated WIF-B
cells; concomitantly we observed delayed progression of
three markers from the basolateral surface. All of these re-
sults are consistent with the current model.
In contrast, the block we observed at a late endocytic step
in the apical pathway is not consistent with the existing
model. Disruption of EEA1 function in the fusion of early
endosomes arising from the apical surface should have
blocked an earlier step in the pathway. However, a subpopu-
lation of EEA1 near the apical surface remained membrane-
bound under PI(3)P-depleting conditions, suggesting that
the protein remained active and allowed progression of en-
docytosed proteins along the apical route, thereby revealing
a block downstream.
These results raise the following question: what mecha-
nism retains EEA1 on the apical endosomes? A simple expla-
nation is that residual Vps34p activity generated sufficient
PI(3)P at this location to support EEA1 binding and func-
tion. Alternatively, since EEA1 encodes two rab5 binding
domains, and rab5 labeled similar apical structures in treated
cells to those with residual EEA1, the presence of rab5 alone
might be sufficient to retain the protein. However, we were
unable to localize syntaxin13, another important player in
the current model, to apical endosomes under any condi-
tions, implying that a different t-SNARE might be serving
the docking/fusion role in this pathway. Together these re-
sults point to a different mechanism operating in the apical
pathway.
Although the defects observed in apical endocytic traffick-
ing do not conform to the current model for mammalian
cells, they are strikingly similar to the endocytic defects ob-
served in yeast expressing temperature-sensitive Vps34p al-
leles (Wurmser and Emr, 1998). At the restrictive tem-
perature, endocytosis of the lipophilic dye, FM4-64 was
impaired and accumulated in prevacuolar compartments.
Similarly, vacuole delivery of the PM a-factor transporter,
Ste6p, was impaired at a late endocytic step. Ultrastructural
analysis further revealed an accumulation of aberrant mem-
brane compartments at the nonpermissive temperature. Are
these structures equivalent to prelysosomes? Does Vac1p
(the yeast EEA1 homologue) remain membrane-associated
at the restrictive temperature?
In addition to the differential effects of Vps34p inhibition
we observed in this study, marker analysis points to impor-
tant biochemical differences between apical and basolateral
early endosomes in WIF-B cells (Fig. 10). Not only was syn-
taxin 13 absent from the apically located endosomes, but
these structures also contained the late endosomal marker,
M6P-R. The presence of both early and late endocytic
markers on the same structure is a puzzle. Perhaps the early
endocytic intermediates at the apical surface are less distinct
than those at the basolateral domain and/or the markers are
present on different domains of the same organelle that are
specialized for specific membrane transport/sorting func-
tions. Alternatively, the presence of M6P-R on the apically-
located puncta may reflect a rate-limiting step in the traf-Vps34p regulates membrane transport in hepatocytes | Tuma et al. 1205
ficking of this recycling receptor through the apical early en-
dosome that it does not encounter when trafficking through
basolateral early endosomes. Thus, M6P-R is not serving as
a late endosomal marker in the apical endocytic pathway.
Does Vps34p differentially regulate endocytosis in 
other polarized epithelial cells?
Our results in hepatic cells lead to several questions. Are the
apical and basolateral pathways in other polarized epithelial
cells also differentially regulated by Vps34p? Wortmannin
treatment of MDCK, Caco2 and FRT cells inhibited transcy-
tosis in both directions, but the specific steps that were per-
turbed were not identified (Cardone and Mostov, 1995;
Hansen et al., 1995). We reported that vacuoles formed in
wortmannin-treated MDCK cells, but did not characterize the
compartment. A related question is whether domain-specific
proteins that are expressed in nonpolarized cells exhibit differ-
ential responses to Vps34p inhibition? Too few membrane pro-
teins have been examined to currently answer this last question.
Like in WIF-B cells, EEA1 exhibits a polarized distribu-
tion in MDCK cells and is localized to basolateral and apical
early endosomes that also contain rab5 (Leung et al., 2000).
Importantly, the apical early endosome in MDCK cells is
also biochemically distinct from the apical-recycling endo-
some (ARE), because neither EEA1 nor rab5 were found on
the ARE. Furthermore, both apical-recycling receptors and
basolateral-to-apical–transcytosing molecules pass through
the ARE as the last stop before delivery to the apical PM,
whereas only the transcytosing proteins were excluded from
the apical early endosome. Thus, just as the apical early en-
dosome is distinct from the ARE in MDCK cells, the WIF-B
apical endosome identified in this study is distinct from the
SAC. However, unlike the ARE, there is currently no evi-
dence to support a role for the SAC in apical recycling (Barr
et al., 1995). An open question is whether ARE/SAC and
apical early endosomes are present as distinct compartments
in nonpolarized cells.
Do the apical and basolateral endocytic pathways 
intersect in hepatic cells?
The intersection of the apical and basolateral degradative en-
docytic pathways has been well-characterized in polarized
MDCK cells and absorptive intestinal cells in situ (Bomsel
et al., 1989; Parton et al., 1989; Fujita et al., 1990). In par-
ticular, fluid phase markers internalized from either domain
in MDCK cells found to converge in late endosomes and
with increased incubation times were detected in lysosomes
(Bomsel et al., 1989; Parton et al., 1989), indicating that the
two pathways intersected at late endosomes and shared the
subsequent endocytic intermediates en route to lysosomes.
However, the extent to which the endocytic intermediates
are shared by molecules internalized from either domain in
hepatic cells is not known. Recently, apically internalized
markers were detected in hepatocytes in situ after retrograde
infusion via the bile duct (Rahner et al., 2000). Confocal
analysis suggested that the apical markers were delivered to
late endosomes and/or lysosomes that also received basolat-
erally internalized fluid phase markers. In our study, we
identified at least four intermediates of the basolateral en-
docytic pathway in WIF-B cells (Fig. 10); these compart-
ments are similar to those described in hepatocytes in situ
(Wall and Hubbard, 1985; Dunn et al., 1986). From these
combined results, we propose that markers internalized from
both PM surfaces converge in late endosomes and proceed
through prelysosomes to mature lysosomes (Fig. 10).
Class IA kinases and membrane traffic
Injection of p110  antibodies impaired basolateral-to-apical
transcytosis of 5 NT as did anti-Vps34p injection. How-
ever, increased 5 NT basolateral surface staining was ob-
served with no corresponding intracellular accumulations of
transcytosing 5 NT. This result suggests that Vps34p and
p110  act at separate steps of the pathway, with p110  pos-
sibly acting at internalization (Fig. 10). Why did injected
nSH2 have no effect on transcytosis? Since this domain in
p85 mediates binding of the regulatory subunit to activated
receptor tyrosine kinases and their substrates which then ac-
tivate p110 (Rordorf-Nikolic et al., 1995), its lack of effect is
significant. Unlike the antibodies that should block all cata-
lytic activity, the nSH2 domains were not expected to in-
hibit p85/p110 basal activity. The nSH2 domains were also
not expected to disrupt activation of p110 kinase activity by
activated CDC42 binding to p85 (Zheng et al., 1994). This
is particularly important given the recent role described for
CDC42 in polarized protein trafficking (Kroschewski et al.,
1999). Thus, regulation of p85/p110 by non-SH2–medi-
ated interactions may be important for transcytosis in polar-
ized cells. Alternatively, the levels of injected nSH2 were not
high enough to be inhibitory or this domain does not func-
tion as a dominant negative inhibtor in WIF-B cells.
Figure 10. Endocytic and transcytotic pathways in polarized he-
patic cells. (A) The intermediates of the transcytotic (top of cell) and 
endocytic intermediates (bottom of cell) are shown with arrows
indicating possible transport routes. (B) The specific markers local-
ized to these intermediates are indicated. Only two intermediates in 
the basolateral-to-apical transcytotic pathway have been identified: 
the basolateral early endosome and SAC. We propose that basolat-
eral endocytosis proceeds sequentially through four intermediates: 
basolateral early endosomes, late endosomes, prelysosomes/MVB, 
(PLC/MVB) and finally, lysosomes. We further propose that apical 
endocytosis proceeds through an apical early endosome that is
distinct from both the basolateral early endosome and the SAC, and 
converges with the basolateral endocytic pathway in M6P-R–
positive late endosomes. The possible transport blocks imposed by 
wortmannin, anti-Vps34p, or anti-p110  are indicated in A.1206 The Journal of Cell Biology | Volume 154, Number 6, 2001
Regulation of membrane homeostasis by PI(3)P lipids
Some puzzling issues remain. First, the inhibition by wort-
mannin or anti-Vps34p observed at the different transport
steps is not complete. That is, transcytosing apical proteins
eventually reach the apical PM and internalized resident api-
cal proteins are eventually delivered to lysosomes for degra-
dation. One explanation is that the class II PI-3 kinases that
are insensitive to anti-Vps34p injection or low wortmannin
concentrations are producing sufficient levels of PI(3)P to
maintain a small flow of membrane transport. Alternatively,
PI(3)P lipids are not an absolute requirement for membrane
transport; they, and the proteins they recruit, merely facili-
tate or increase the efficiency of the process.
Another puzzle is the basis for formation of transiently
and/or permanently enlarged compartments when PI(3)P
levels are altered. One explanation is that vesicle transport to
a compartment occurs while the corresponding efflux from
the compartment is impaired. Consistent with this possibil-
ity is the finding that pretreatment with nocodazole blocks
vacuole formation in wortmannin (Tuma et al., 1999) and
anti-Vps34p–treated cells (unpublished data). Thus, vacuole
formation predominantly results from defects in vesicle-
mediated transport. Although this explanation accounts for
the formation and subsequent enlargement of the endolyn-
78–positive prelysosomes, it does not account for the tran-
sient nature of the early and late endosomal vacuoles. One
possibility is that vacuole formation may also reflect an al-
tered distribution of functional proton pumps in treated
cells. Hepatic lysosomes and endosomes are acidified by spe-
cific sets of H( )-ATPases (Van Dyke, 1996). The proton
gradients they establish likely provide the energy necessary
for transport of ions or solutes into and out of endosomes
and lysosomes by specific transporters. As we showed in this
study with lysotracker, and others have shown with acridine
orange (Brown et al., 1995), wortmannin does not dissipate
the pH gradient across the endosome or lysosome mem-
brane. In fact, treatment with the proton-ATPase inhibitor,
bafilomycin, not only prevented vacuole formation, but also
rapidly collapsed preformed vacuoles (unpublished data).
Thus, compartment acidification is required for vacuole for-
mation and maintenance. Accordingly, transient vacuole
formation may reflect imbalances in the net uptake of ions
and solutes resulting from changes in the numbers of trans-
porters and proton pumps present in each compartment.
Such altered steady state distributions may be explained by
the defects in membrane trafficking caused by PI(3)P. Alter-
natively, PI(3)P may be directly required for proper pump
and transporter function, as has been demonstrated for sister
of P-glycoprotein and MRP2 (Misra et al., 1999). In this
case, depletion of PI(3)P from membranes may differentially
inhibit pump or transporter activity. Whatever the explana-
tion, it is clear that PI(3)P plays many important regulatory
roles in membrane traffic in polarized hepatic cells.
Materials and methods
Materials and antibodies
10 mM wortmannin in DMSO and 5 mM leupeptin in 10% DMSO (Sigma-
Aldrich) were stored at  20 C. Antibodies were from the following
sources: anti-RSA from Cappel Research Products; Alexa-conjugated sec-
ondary antibodies were from Molecular Probes; monoclonal anti-EEA1
were from Transduction Laboratories. The antibodies recognizing EEA1,
5 NT, MRP2, M6P-R, rab5, syntaxin13, and cathepsin D were from S. Cor-
vera, (University of Massachusetts, Worcester, MA), J.P. Luzio (Cambridge
University, Cambridge, UK), D. Keppler (Deutsches Krebsforschungszen-
trum, Heidelberg, Germany), P. Nissley (National Institutes of Health, Be-
thesda, MD), M. Wessling-Resnick and G. Quellhorst (Harvard School of
Public Health, Boston, MA), R. Scheller and V. Prekeris (Stanford Univer-
sity School of Medicine, Stanford, CA), and J. Blum and P. Stahl (Washing-
ton University School of Medicine, St. Louis, MO), respectively. LGP-120
polyclonal antibodies were from W. Dunn (University of Florida, Gaines-
ville, FL) and LGP-120 monoclonal antibodies (GM10) were from K. Siddle
and J. Hutton (University of Cambridge, Cambridge, UK). The SH2–GST
fusion protein and antibodies against p110 , p110 , and Vps34p were
prepared in the Backer laboratory and have been described elsewhere
(Siddhanta et al., 1998; Hill et al., 2000). Antibodies against APN, ASGP-R,
endolyn-78, DPP IV, and GST were prepared in the Hubbard laboratory
and have been described elsewhere (Barr and Hubbard, 1993; Ihrke et al.,
1993, 1998; Fujita et al., 1998).
Cell culture
WIF-B cells were grown in a humidified 7% CO2 incubator at 37 C as de-
scribed (Shanks et al., 1994). In brief, cells were grown in F12 medium
(Coon’s Modification; Sigma-Aldrich), pH 7.0, supplemented with 5%
FBS, 10  M hypoxanthine, 40 nM aminoterpin, and 1.6  M thymidine.
For injection and indirect immunofluorescence, cells were seeded onto
glass coverslips at 1.3   10
4 cells/cm
2 and cultured for 8–12 d (Ihrke et al.,
1993; Shanks et al., 1994).
Microinjection
Cells grown on coverslips were placed in prewarmed, Hepes-buffered (20
mM, pH 7.0), serum-free medium (HSFM) and were injected over a 10–15-
min period using an Transjector 5246 and Micromanipulator 5171 with
commercially purchased microneedles (Eppendorf) and then placed in
complete medium at 37 C to recover. The injected antibodies and SH2-
GST (2–4 mg/ml) were prepared in PBS, pH 7.4. Injected cells were de-
tected by staining for the injected antibodies directly with Alexa 488–con-
jugated secondary antibodies (3  g/ml), or for the fusion protein, by first
applying anti-GST primary antibodies (affinity-purified, rabbit polyclonal
antibody, 2.5  g/ml) followed by detection with Alexa 488–conjugated
antibodies (3  g/ml).
Immunofluorescence microscopy
Injected cells were incubated for 4 h at 37 C before fixation. Treated cells
were incubated at 37 C in HSFM in the absence or presence of 100 nM
wortmannin or 50  M leupeptin (see figure legends for details). Cells were
rinsed briefly in PBS and placed on ice, fixed with chilled PBS containing
4% paraformaldehyde for 1 min, and permeabilized with ice-cold metha-
nol for 10 min (Ihrke et al., 1993). Cells were further processed for indirect
immunofluorescence according to previously published methods (Ihrke et
al., 1993, 1998) with the following primary antibodies: anti–ASGP-R,
–M6P-R, –MRP2, –LGP-120, –cathepsin D, -APN and -syntaxin13 (rabbit
polyclonals, 1:100, 1:200, 1:200, 1:200, 1:200, 1:300, and 1:1,000, re-
spectively), anti-5 NT, –endolyn-78, -EEA1, –DPP IV, and –GM10 (mouse
monoclonal ascites, 1:300, 1:500, 1:50, 1:100, and 1:100, respectively).
Cells stained for rab5 (affinity-purified rabbit polyclonal antibody, 1:200)
were prepermeabilized for 2 min at room temperature with PBS containing
0.2% Triton X-100. After rinsing with PBS, the cells were fixed with 4%
paraformaldehyde/PBS for 30 min at room temperature. The secondary an-
tibodies (Alexa 488– or 568–conjugated) were used at 3–5  g/ml. For ex-
periments using lysotracker, cells were treated with 100 nM wortmannin
for 3 h at 37 C. During the last 30 min of incubation, 50 nM lysotracker
(Molecular Probes) was added to the medium. After extensive rinsing with
prewarmed medium, live cells were imaged directly by epifluorescence.
Preparation of samples for biochemical analysis
WIF-B cells were treated with 100 nM wortmannin in HSFM for the de-
sired times at 37 C. The medium was aspirated and the cells detached by
adding trypsin (137 mM NaCl, 5.4 mM KCl, 0.5 mM EDTA, 0.058%
NaHCO3, 0.05% trypsin, pH 7.4) and pelleted by centrifugation. The cells
were resuspended in 5 ml of ice-cold swelling buffer (1 mM MgCl2, 1 mM
DTT, 1 mM EGTA) and incubated for 5 min on ice. Cells were pelleted by
centrifugation, resuspended to a final concentration of 10–20   10
6 cells/
ml in 0.25 M sucrose, 3 mM imidazole, pH 7.4, with added protease in-
hibitors (1  g/ml each of leupeptin and antipain, 1 mM each of PMSF and
benzamidine and 100 KIU/ml trasylol), and homogenized for 10 strokes
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ther mixed with SDS-PAGE sample buffer directly or centrifuged for 45
min at 125,000 g at 4 C. The resultant pellet was resuspended to volume
and both the supernatant and pellet samples were mixed with SDS-PAGE
sample buffer and separated by gel electrophoresis. Polypeptides were
transferred onto nitrocellulose and the Western blots were assayed for im-
munoreactivity with anti-EEA1 (rabbit polyclonal; 1:5,000) and ECL detec-
tion of HRP-conjugated secondary antibodies (Amersham Pharmacia Bio-
tech). The relative levels of immunoreactive species were determined by
densitometric comparison of immunoreactive bands (Microcomputer Im-
aging Device, Imaging Research, Inc.).
Trafficking assay
The transcytosis assays were performed as described (Ihrke et al., 1998). In
brief, injected cells were recovered for 2 h at 37 C and then placed on ice
for 5 min. Cells were labeled at 4 C for 15 min with anti-5 NT (IgG puri-
fied from monoclonal ascites using EZ-Sep (Amersham Pharmacia Biotech;
20  g/ml) diluted in HSFM containing 2 mg/ml BSA. Since tight junctions
restrict antibody access to the apical surface, only the 5 NT molecules
present at the basolateral surface were labeled. The cells were washed in
HSFM containing 2 mg/ml BSA then placed in complete medium, returned
to 37 C, and incubated for 3 h. The cells were fixed and permeabilized as
described above and the trafficked antibodies were labeled with Alexa
568–conjugated secondary antibodies (5  g/ml). Injected cells were
scored for the presence of intracellular 5 NT or for the relative immunoflu-
orescence signal detected at the apical PM (see the legend to Fig. 4 for de-
tails). For experiments in Fig. 5, uninjected cells were labeled and antibod-
ies were trafficked as above. After 5 h of chase at 37 C, cells were placed
in HSFM and injected with anti-Vps34p. They were returned to complete
medium, incubated an additional 4 h at 37 C, fixed, permeabilized, and
labeled with secondary antibodies as described above. For experiments
shown in Figs. 7 and 9, cells were pretreated for 2 h with 100 nM wort-
mannin. Antibodies diluted in HSFM containing 2 mg/ml BSA and 100 nM
wortmannin were continuously applied for an additional hour at 37 C and
the cells were processed as above. For Fig. 8, endolyn at the basolateral
surface was continuously labeled for 1 h at 37 C and the cells processed as
above.
Imaging
Immunofluorescence was analyzed using a laser scanning confocal micro-
scope (Oz; Noran) for Figs. 1; 2; 3, a, b, e, and f; 5, a–f; and 8, a–d and
m–f. For all other figures, labeled cells were visualized by epifluorescence
(Axioplan Universal Microscope, ZEISS). Images were acquired with a
Princeton MicroMax 1300Y cooled CCD camera (Roper Scientific) and IP
Labs software (Scanalytics). Further image processing and figure compila-
tion were done using Adobe Photoshop
® and Microsoft PowerPoint soft-
ware.
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